CDX2 and gastric cancer: Analyses of publicly available databases (Kaplan-Meier plotter and The Cancer Genome Atlas) showed that GC patients with higher levels of CDX expression had significantly better clinical outcomes.60In vitro, the overexpression of CDX2 inhibited the growth and invasion of GC cells (MKN45 cells) and reversed epithelial-to-mesenchymal transformation (EMT).